Search research articles
Contact Us
Filters
Showing results (131-140 of 176) with videos related to
Page
of 18
Sort By:
Frontiers in Oncology
|
May 8, 2026
Phase II study of magrolimab combined with docetaxel in previously treated metastatic advanced solid tumors
Antoine Italiano, Teresa García Manrique, Enrique Grande Pulido, et al.
Cancer
|
March 26, 2020
Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell-free DNA results
Sumanta K Pal, Dean Bajorin, Nazli Dizman, et al.
Oncology
|
April 20, 2023
Radiogenomic Associations Clear Cell Renal Cell Carcinoma: An Exploratory Study
Derek H Liu, Komal A Dani, Sharath S Reddy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2026
Correlative Biomarker Analysis of PSMA Expression on CTCs and PSMA Imaging in a Phase I Study of PSMA Targeted Tubulysin Conjugate EC1169
Samir Zaidi, Phillip H Kuo, Tiago Paiva Prudente, et al.
Nutrients
|
June 19, 2024
Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic Therapy
Hedyeh Ebrahimi, Dena Battle, Nicholas J Salgia, et al.
Nature Medicine
|
January 13, 2026
Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial
Timothy A Yap, Randy F Sweis, Ulka Vaishampayan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 7, 2021
Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study
Sumanta K Pal, Bradley McGregor, Cristina Suárez, et al.
The American Journal of Surgical Pathology
|
November 23, 2023
Hybrid Oncocytic Tumors (HOTs) in Birt-Hogg-Dubé Syndrome Patients-A Tale of Two Cities: Sequencing Analysis Reveals Dual Lineage Markers Capturing the 2 Cellular Populations of HOT
Xiao-Ming Wang, Rahul Mannan, Yuping Zhang, et al.
European Urology Oncology
|
December 2, 2019
Outcomes of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy After Immuno-oncology Checkpoint Inhibitors
Jeffrey Graham, Amishi Y Shah, J Connor Wells, et al.
Lancet (London, England)
|
February 16, 2021
A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial
Sumanta K Pal, Catherine Tangen, Ian M Thompson, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 176) with videos related to
Sort By:
Page
of 18
Frontiers in Oncology
|
May 8, 2026
Phase II study of magrolimab combined with docetaxel in previously treated metastatic advanced solid tumors
Antoine Italiano, Teresa García Manrique, Enrique Grande Pulido, et al.
Cancer
|
March 26, 2020
Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell-free DNA results
Sumanta K Pal, Dean Bajorin, Nazli Dizman, et al.
Oncology
|
April 20, 2023
Radiogenomic Associations Clear Cell Renal Cell Carcinoma: An Exploratory Study
Derek H Liu, Komal A Dani, Sharath S Reddy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2026
Correlative Biomarker Analysis of PSMA Expression on CTCs and PSMA Imaging in a Phase I Study of PSMA Targeted Tubulysin Conjugate EC1169
Samir Zaidi, Phillip H Kuo, Tiago Paiva Prudente, et al.
Nutrients
|
June 19, 2024
Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic Therapy
Hedyeh Ebrahimi, Dena Battle, Nicholas J Salgia, et al.
Nature Medicine
|
January 13, 2026
Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial
Timothy A Yap, Randy F Sweis, Ulka Vaishampayan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 7, 2021
Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study
Sumanta K Pal, Bradley McGregor, Cristina Suárez, et al.
The American Journal of Surgical Pathology
|
November 23, 2023
Hybrid Oncocytic Tumors (HOTs) in Birt-Hogg-Dubé Syndrome Patients-A Tale of Two Cities: Sequencing Analysis Reveals Dual Lineage Markers Capturing the 2 Cellular Populations of HOT
Xiao-Ming Wang, Rahul Mannan, Yuping Zhang, et al.
European Urology Oncology
|
December 2, 2019
Outcomes of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy After Immuno-oncology Checkpoint Inhibitors
Jeffrey Graham, Amishi Y Shah, J Connor Wells, et al.
Lancet (London, England)
|
February 16, 2021
A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial
Sumanta K Pal, Catherine Tangen, Ian M Thompson, et al.
Page
of 18